NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.62
0.00 (0.65%)
At close: May 23, 2025, 3:59 PM
0.59
-5.95%
After-hours: May 23, 2025, 05:15 PM EDT

NeuroOne Medical Statistics

Share Statistics

NeuroOne Medical has 49.82M shares outstanding. The number of shares has increased by 10.85% in one year.

Shares Outstanding 49.82M
Shares Change (YoY) 10.85%
Shares Change (QoQ) 0.07%
Owned by Institutions (%) 6.05%
Shares Floating n/a
Failed to Deliver (FTD) Shares 3
FTD / Avg. Volume n/a

Short Selling Information

The latest short interest is 390.88K, so 0.82% of the outstanding shares have been sold short.

Short Interest 390.88K
Short % of Shares Out 0.82%
Short % of Float 0.85%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -2.15 and the forward PE ratio is -4.06. NeuroOne Medical's PEG ratio is 0.07.

PE Ratio -2.15
Forward PE -4.06
PS Ratio 7.67
Forward PS 1.3
PB Ratio 32.23
P/FCF Ratio -2.38
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NeuroOne Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.32.

Current Ratio 2.09
Quick Ratio 0.9
Debt / Equity 0.32
Debt / EBITDA -0.02
Debt / FCF -0.02
Interest Coverage -51.91

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $203,117.82
Profits Per Employee $-724,594.71
Employee Count 17
Asset Turnover 0.64
Inventory Turnover 0.9

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -41.51% in the last 52 weeks. The beta is 0.65, so NeuroOne Medical's price volatility has been higher than the market average.

Beta 0.65
52-Week Price Change -41.51%
50-Day Moving Average 0.69
200-Day Moving Average 0.86
Relative Strength Index (RSI) 45.96
Average Volume (20 Days) 298,877

Income Statement

In the last 12 months, NeuroOne Medical had revenue of 3.45M and earned -12.32M in profits. Earnings per share was -0.46.

Revenue 3.45M
Gross Profit 1.08M
Operating Income -11.89M
Net Income -12.32M
EBITDA -11.84M
EBIT -12.09M
Earnings Per Share (EPS) -0.46
Full Income Statement

Balance Sheet

The company has 1.46M in cash and 260.16K in debt, giving a net cash position of 1.2M.

Cash & Cash Equivalents 1.46M
Total Debt 260.16K
Net Cash 1.2M
Retained Earnings -75M
Total Assets 4.46M
Working Capital 1.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.01M and capital expenditures -120.2K, giving a free cash flow of -11.13M.

Operating Cash Flow -11.01M
Capital Expenditures -120.2K
Free Cash Flow -11.13M
FCF Per Share -0.42
Full Cash Flow Statement

Margins

Gross margin is 31.27%, with operating and profit margins of -344.26% and -356.74%.

Gross Margin 31.27%
Operating Margin -344.26%
Pretax Margin -356.74%
Profit Margin -356.74%
EBITDA Margin -342.96%
EBIT Margin -344.26%
FCF Margin -322.39%

Dividends & Yields

NMTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for NMTC is $1.45, which is 133.9% higher than the current price. The consensus rating is "Buy".

Price Target $1.45
Price Target Difference 133.9%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Apr 1, 2021. It was a backward split with a ratio of 1:3.

Last Split Date Apr 1, 2021
Split Type backward
Split Ratio 1:3

Scores

Altman Z-Score -20.19
Piotroski F-Score 4